VeClose trial Cyanoacylate closure vs. RF ablation 36-month results

Size: px
Start display at page:

Download "VeClose trial Cyanoacylate closure vs. RF ablation 36-month results"

Transcription

1 VeClose trial Cyanoacylate closure vs. RF ablation 36-month results LINC 2018, Leipzig 31 st Jan 2018 Tobias Hirsch, Halle, Germany

2

3 Disclosure Tobias Hirsch I have the following potential conflicts of interest to report: Consulting (Medtronic, Sigvaris, L+R, Medi, Bauerfeind) Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s) I do not have any potential conflict of interest

4 Thermal ablation is standard USA: American Venous Forum 2011 UK: NICE Guidelines 2013

5 High occlusion rate! Laser: 93.0% (3yr) RFA: 93.2% Stripping: 93.5% Rasmussen et al., JVascSurg 2013 USA: American Venous Forum 2011 UK: NICE Guidelines 2013

6 High occlusion rate! Laser: 84.8% (5yr) RFA: 88.7% Stripping: 93.5% Balint et al., Vascular 2016 (862 articles, 17 RCT) USA: American Venous Forum 2011 UK: NICE Guidelines 2013

7 Laser: 12 devices 940nm nm 1320nm 1470nm (810nm) Bare fibre Radial Radial 2ring RFA: 3 systems ClosureFast TM RFiTT EVRF FCare

8 Do we need more methods and devices?

9 Thermal ablation has side effects Heat Tumescent anesthesia

10 Thermal ablation has side effects Heat Tumescent anesthesia Needle

11 Thermal ablation has side effects Heat Tumescent anesthesia Pain Hyperpigmentation Risk of nerve damage Needle

12 Non-thermal ablation using adhesive closure

13

14

15

16

17 Adhesive closure History Methyl 2-cyanoacrylate 1960s nerve lesions Isobutyl 2-cyanoacrylate 1970s wound closure N-octyl-cyanoacrylate 1996 wound closure N-butyl 2-cyanoacrylate 1989 intravascular use

18 Adhesive closure History Methyl 2-cyanoacrylate 1960s nerve lesions Isobutyl 2-cyanoacrylate 1970s wound closure N-octyl-cyanoacrylate 1996 wound closure N-butyl 2-cyanoacrylate 2011 Venaseal TM

19 Adhesive closure Occlusion rate 90,3-100,0% Hirsch T, Phlebologie 2017(46)143-7

20 VeClose Study Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

21 VeClose Study Overview Title Purpose VenaSeal Closure System vs. Radiofrequency Ablation for Incompetent Great Saphenous Veins Demonstrate the safety and effectiveness of the VenaSeal Closure System for the treatment of lower extremity truncal reflux compared to RFA (ClosureFAST TM system) Study Design Enrollment Sites Follow-up US multi-center, randomized controlled IDE study. The study takes a noninferiority approach to effectiveness for anatomical closure at 3 months. Effectiveness at 36 months is assessed and compared across groups. 242 (20 roll-in and 222 randomized) subjects enrolled at 10 study sites (Sept 2013) Follow-up visits at 3 days post-procedure, 1, 3, 6, 12, 24, 36 and 60 months. Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

22 VeClose Study Sites and Enrollments Intraoperative Pain evaluation : Site # Site Name Following procedure, self PI rated pain experienced Location during 2 phases of the treatment procedure on a 0-10 NRS 11 Morrison Vein Institute Phase 1: From initial Morrison local anesthesiascottsdale, injection AZ at the access 2 site to 14 Primary Endpoint Secondary Endpoints Complete closure of the target vein at 3 months after index Roll-in procedure as judged by the core laboratory. Complete closure is defined as Doppler ultrasound examination showing closure along venous entire access treated with the target micro-access vein segment catheter with no discrete segments of patency exceeding 5 cm. Phase 2: From introduction of the RFA or CAC catheter to completion of vein treatment and device removal Ecchymosis at Day 3: Investigator assessment of ecchymosis along the treated area using a 0-5 point grading scale 0 - none 1 - involving <25% of the treatment area 2-25%-50% 3-50%-75% 4-75%-100% McEnroe Virginia Beach, VA extension above or below the treatment segment Morrison N, Gibson K, McEnroe S et al., J Vasc Surg Randomized 12 Vein Clinics of America King, Hlavcek Oakbrook Terrace, IL Inovia Vein Specialty Center Jones Bend, OR Lake Washington Vascular Gibson Bellevue, WA Radiology Imaging Associates Spencer Greenwood Village, CO GBK Cosmetic Laser Dermatology Goldman San Diego, CA Prairie Education & Research Cooperative Kolluri, Matos Springfield, IL Maryland Laser Skin & Vein Institute Weiss Hunt Valley, MD Vein Center of Virginia/Sentara Vascular Specialists 22 Venous Institute of Buffalo Vasquez Amherst, NY

23 VeClose Study Endpoints Primary Endpoint Complete closure of the target vein at 3 months after index procedure as judged by the core laboratory. Complete closure is defined as a Doppler ultrasound examination showing closure along entire treated target vein segment with no discrete segments of patency exceeding 5 cm. Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

24 VeClose Study Endpoints Primary Endpoint Secondary Endpoints Intraoperative pain evaluation: Following procedure, self rated pain experienced during 2 phases of the treatment procedure on a 0-10 NRS Phase 1: From initial local anesthesia injection at the access site to Complete closure of the target vein at 3 months after index procedure as judged by the core laboratory. Complete closure is defined as Doppler ultrasound examination showing closure along venous entire access treated with the target micro-access vein segment catheter with no discrete segments of patency exceeding 5 cm. Phase 2: From introduction of the RFA or CAC catheter to completion of vein treatment and device removal Ecchymosis at day 3: Investigator assessment of ecchymosis along the treated area using a point scale of none 1 - involving <25% of the treatment area 2-25%-50% 3-50%-75% 4-75%-100% 5 - extension above or below the treatment segment Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

25 VeClose Study Endpoints Additional endpoints Assessments related to venous disease severity: Change in VCSS scores Change in CEAP scores Assessments related to QoL: Change in AVVQ scores Change in EQ-5D TTO scores Comparison of adverse event rates related to target GSV AVVQ, Aberdeen Varicose Vein Questionnaire; CEAP, Clinical-Etiology-Anatomy-Pathophysiology classification; GSV, great saphenous vein; EQ-5D, EuroQoL 5 Dimension; QoL, Quality of Life; TTO, time trade-off; VCSS, vein clinical severity score. Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

26 VeClose Study Design Enrolled (N=242) Randomized (1:1) and treated Subjects (N=222) CAC Roll-In group Subjects (N=20) CAC (n=108) RFA (n=114) Evaluation of perioperative parameters Baseline assessments Intraoperative pain Ecchymosis Follow up at day 3; and at 1,3,6, 12, 24, 36, 60 months Reevaluation of clinical assessments and adverse events Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

27 VeClose Study Demographic and Baseline Characteristics Baseline Characteristics CAC (N=108) RFA (N=114) P-value Age (years) Body Mass Index Mean GSV diameter (mm) Proximal Mid-thigh Mean treatment length (cm) 32.8 (108) 35.1 (114) 0.17 Mean VCSS 5.5 ± ± Mean AVVQ 18.9 ± ± AVVQ, aberdeen varicose vein questionnaire; CEAP, clinical-etiology-anatomy-pathophysiology classification; GSV, great saphenous vein; EQ-5D, euro quality of life-5d; QoL, quality of life; TTO, time Mean trade-off; EQ-5D VCSS, TTOvein clinical severity score ± ± Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

28 VeClose Study Pain Scores Tumescent anesthesia volume (ml) CAC (N=108) Not applicable RFA (N=114) Lidocaine use (ml) Cyanoacrylate delivered (ml) 1.2 N/A - Intraoperative pain P-value During vein access During treatment Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

29 VeClose Study Ecchymosis at Day 3 Assessed by investigators with a 5-point scale on day 3 Subjects treated with VenaSeal system had significantly less ecchymosis on day 3 compared to RFA (p< 0.01). Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

30 VeClose Study Primary Endpoint Complete Closure Time Point VenaSeal RFA Day 3 100% (108) 99.1% (114) Month 1 100% (105) 87.3% (110) Month 3* 99% (104) 95.4% (108) Month 6 99% (101) 96.2% (105) Month % (95) 95.9% (97) Month % (86) 94% (84) Month % (72) 91.9% (74) Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

31 VeClose Study Primary endpoint Complete Closure Time Point VenaSeal RFA Day 3 100% (108) 99.1% (114) Month 1 100% (105) 87.3% (110) Month 3* 99% (104) 95.4% (108) Month 6 99% (101) 96.2% (105) Month % (95) 95.9% (97) Month % (86) 94% (84) Month % (72) 91.9% (74) Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

32 VeClose Study Primary endpoint Complete Closure Month % (72) 91.9% (74) Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

33 VCSS, Mean (SE) VeClose Study VCSS: disease severity over time Follow-up Months RFA 1.69 ± 2.42 VS 1.25 ± 1.60 p= Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

34 AWQ, Mean (SE) VeClose Study AVVQ: pain, edema, skin changes, compression use RFA 8.21 ± 7.76 VS 7.33 ± 6.19 p= Follow-up Months Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

35 EQ-5D Health Thermometer, Mean (SE) VeClose Study EQ-5D: mobility, self-care, usual activities, pain, anxiety 100 VS ± RFA ± p= Follow-up Months Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

36 VeClose Study Adverse Events Month AE Device or Procedure Reporting Adverse Events Reported Device/ Procedure Related CAC 2 (phlebitis, scar at access site) RFA 0 VenaSeal AEs from 0 to 36 months: No reports of deep vein thrombus No allergic events reported No unanticipated adverse events Most events occurred in the first 30 days, were mild and self-limiting Delayed adverse events were minimal to non-existent Morrison N, Gibson K, McEnroe S et al., J Vasc Surg

37 Roll-in Phase Analysis of clinical study of CAC for incompetent GSV Objectives: Efficacy and safety outcomes of the VeClose roll-in (training) group vs. randomized CAC/RFA Results: Mean procedure 3min longer 3-month closure rate 100% Procedural pain, post-procedural QoL, AE similar Despite the physician s lack of prior experience, initial treatment with CAC leads to comparable efficacy and safety results to RFA and is associated with a relatively short learning period. Kolluri R, et al. J Vasc Surg and Lym Dis 2016;4;407-15

38 VeClose Study Summary at 36 Months 1. VenaSeal procedure resulted in a reported closure rate of 94.4%, demonstrating continued, noninferiority compared to RFA (P=0.005) 2. VCSS, AVVQ and EQ-5D outcomes demonstrated statistically significant improvement from baseline with sustained results over time; no difference between treatment groups 3. No reported DVTs, allergic reactions, or other SAEs. Early events were mild and self-limiting; delayed events were uncommon 4. VenaSeal is easy to learn

39 Thank you for your attention! Tobias Hirsch Vein Competency Centre Halle

40 See you at the social dinner! Tobias Hirsch and his marvellous Valentine B Live at Moritzbastei Feb 1 st 2018

MOCA and GLUE: results and analyses of the RCTs

MOCA and GLUE: results and analyses of the RCTs MOCA and GLUE: results and analyses of the RCTs Faculty disclosure Research Grant Medtronic Educational Grant mediusa Speakers Bureau Medtronic Pierre Fabre mediusa Medical Director Morrison Vein/Training

More information

Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous vein

Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous vein Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous vein Raghu Kolluri, MD, Director Vascular Medicine OhioHealth Riverside Methodist Hospital

More information

Kathleen Gibson, MD. Lake Washington Vascular Surgeons Bellevue, WA

Kathleen Gibson, MD. Lake Washington Vascular Surgeons Bellevue, WA Cyanoacrylate Closure of Incompetent Great, Small and Accessory Saphenous Veins without the use of Post-Procedure Compression: a Post-Market Evaluation of the VenaSeal System (WAVES trial): Three Month

More information

Kathleen Gibson, MD FACS Lake Washington Vascular Surgeons, Bellevue, WA, USA

Kathleen Gibson, MD FACS Lake Washington Vascular Surgeons, Bellevue, WA, USA Cyanoacrylate Closure of Incompetent Great, Small and Accessory Saphenous Veins without the use of Post-Procedure Compression: Post-Market Evaluation of the VenaSeal System (WAVES trial): 12 Month Data

More information

Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA

Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA DISCLOSURES Kathleen Gibson, MD Consultant/Advisory Board: BTG, Medtronic Speakers

More information

Criteria For Medicare Members. Kaiser Foundation Health Plan of Washington

Criteria For Medicare Members. Kaiser Foundation Health Plan of Washington Clinical Review Criteria Treatment of Varicose Veins Radiofrequency Catheter Closure Sclerotherapy Surgical Stripping Trivex System for Outpatient Varicose Vein Surgery VenaSeal Closure System VNUS Closure

More information

Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results

Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results Stephen Black Consultant Vascular Surgeon Clinical Lead for Venous and Lymphoedema Surgery Guy s and St Thomas

More information

Why Tumescent-Free Therapy Will Replace RF and Laser

Why Tumescent-Free Therapy Will Replace RF and Laser C SCOTT MCENROE Medical Director Vein Center of Virginia Sentara Medical Group April 27, 2018 Why Tumescent-Free Therapy Will Replace RF and Laser History of Venous Surgery 1950 s GSV/SSV stripping became

More information

Cyanoacrylate vs laser ablation. Turkish experience. A. Kursat Bozkurt MD University of Istanbul

Cyanoacrylate vs laser ablation. Turkish experience. A. Kursat Bozkurt MD University of Istanbul Cyanoacrylate vs laser ablation. Turkish experience A. Kursat Bozkurt MD University of Istanbul Disclosure Speaker name: A. Kursat Bozkurt I have the following potential conflicts of interest to report:

More information

VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins

VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins Nick Morrison, MD, a Kathleen Gibson, MD, b Michael Vasquez, MD, c Robert Weiss,

More information

Thermal Techniques: Outcomes and Complications

Thermal Techniques: Outcomes and Complications Thermal Techniques: Outcomes and Complications Meet The Experts: Thermal and Non-Thermal Ablation Techniques Joseph D. Raffetto MD VA Boston HCS, West Roxbury, MA, Harvard Medical School, Boston, MA; Brigham

More information

Conflict of Interest. None

Conflict of Interest. None Conflict of Interest None American Venous Forum Guidelines on Superficial Venous Disease TOP 10 GUIDELINES 10. We recommend using the CEAP classification to describe chronic venous disorders. (GRADE 1B)

More information

Epidemiology: Prevalence

Epidemiology: Prevalence Epidemiology: Prevalence More than 30 million Americans suffer from varicose veins or a more serious form of venous disease called Chronic Venous Insufficiency (CVI). 1 Of the over 30 million Americans

More information

Public Summary Document

Public Summary Document Public Summary Document Application No. 1472 - Cyanoacrylate embolisation for the treatment of varicose veins due to chronic venous insufficiency Applicant: Medtronic Australasia Pty Ltd Date of MSAC consideration:

More information

Endovenous Thermal vs. Endovenous Chemical Ablation What is the Best for the Patient

Endovenous Thermal vs. Endovenous Chemical Ablation What is the Best for the Patient Endovenous Thermal vs. Endovenous Chemical Ablation What is the Best for the Patient T. Noppeney, J. Noppeney Center for Vascular Diseases: Outpatient Dept. Obere Turnstrasse, Dept. for Vascular Surgery

More information

What can we learn from randomized trials comparing endovenous and open surgery for primary varicosis? an overview Prof. Dr. Thomas M.

What can we learn from randomized trials comparing endovenous and open surgery for primary varicosis? an overview Prof. Dr. Thomas M. What can we learn from randomized trials comparing endovenous and open surgery for primary varicosis? an overview Prof. Dr. Thomas M. Proebstle Department of Dermatology, University Medical Center Mainz,

More information

FIND RELIEF FROM VARICOSE VEINS. VenaSeal Sapheon Closure System

FIND RELIEF FROM VARICOSE VEINS. VenaSeal Sapheon Closure System FIND RELIEF FROM VARICOSE VEINS VenaSeal Sapheon Closure System UNDERSTAND Varicose veins may be a sign of something more severe. Your doctor can help you understand if you have this condition. may cause

More information

Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue)

Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue) Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue) Awais Siddique MD Endovascular Radiologist AZH WAVE CENTERS Milwaukee WI Venous disease Etiology Are the result of Venous valvular

More information

RADIOFREQUENCY ABLATION. Drs PIRET V, BERGERON P MEET CANNES 2009

RADIOFREQUENCY ABLATION. Drs PIRET V, BERGERON P MEET CANNES 2009 RADIOFREQUENCY ABLATION Drs PIRET V, BERGERON P MEET CANNES 2009 Superficial Venous Disease: EPIDEMIOLOGY Touch 75% of french population at different degrees (45.10 6 ) 25% needs medical care (11.10 6

More information

FIND RELIEF FROM VARICOSE VEINS. VenaSeal Closure System

FIND RELIEF FROM VARICOSE VEINS. VenaSeal Closure System FIND RELIEF FROM VARICOSE VEINS VenaSeal Closure System UNDERSTAND Varicose veins may be a sign of something more severe venous reflux disease Your doctor can help you understand if you have this condition.

More information

Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015

Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015 Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015 Anatomy of Perforating veins Cadaveric studies 1 have shown >60 vein perforating veins from superficial to deep Normal

More information

Find From Varicose Veins. VenaSeal

Find From Varicose Veins. VenaSeal Find Relief From Varicose Veins VenaSeal Closure System Understand Varicose veins may be a sign of something more severe venous reflux disease. Your doctor can help you understand if you have this condition.

More information

UNDERSTANDING VEIN DISEASE. UC EN - For use in the U.S. only

UNDERSTANDING VEIN DISEASE. UC EN - For use in the U.S. only UNDERSTANDING VEIN DISEASE UC201706537 EN - For use in the U.S. only Do you need to sit down during your work day because your legs ache and/or swell? Do you miss out on doing the activities you love because

More information

What might bring a new wavelength for endovenous laser? Lowell S. Kabnick, MD, RPhS, FACS

What might bring a new wavelength for endovenous laser? Lowell S. Kabnick, MD, RPhS, FACS What might bring a new wavelength for endovenous laser? Lowell S. Kabnick, MD, RPhS, FACS Division of Vascular and Endovascular Surgery Faculty disclosure Lowell Kabnick, MD NOTHING TO DISCLOSE IS 1950nm

More information

Non-Saphenous Vein Treatments. Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO

Non-Saphenous Vein Treatments. Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO Non-Saphenous Vein Treatments Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO I have no financial disclosures Types of Veins Treated Perforator Veins Tributary Veins Varicose

More information

How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN.

How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN. How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN Surgeon Dr G Mark Malouf Sydney Australia Following History and Physical examination

More information

Endothermal Ablation for Venous Insufficiency. Dr. S. Kundu Medical Director The Vein Institute of Toronto

Endothermal Ablation for Venous Insufficiency. Dr. S. Kundu Medical Director The Vein Institute of Toronto Endothermal Ablation for Venous Insufficiency Dr. S. Kundu Medical Director The Vein Institute of Toronto Objective: remove the GSV from the circulation 1. Surgical - HL & stripping 2. Chemical sclerotherapy

More information

The role of ultrasound duplex in endovenous procedures

The role of ultrasound duplex in endovenous procedures The role of ultrasound duplex in endovenous procedures Neophytos A. Zambas MD, PhD Vascular Surgeon Polyclinic Ygia, Limassol, Cyprus ΚΕΑΕΧ ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΑΓΓΕΙΑΚΗΣ ΚΑΙ ΕΝΔΑΓΓΕΙΑΚΗΣ ΧΕΙΡΟΥΡΓΙΚΗΣ Pre

More information

Patient assessment and strategy making for endovenous treatment

Patient assessment and strategy making for endovenous treatment Patient assessment and strategy making for endovenous treatment Raghu Kolluri, MD Director Vascular Medicine OhioHealth Riverside Methodist Hospital Columbus, OH Disclosures Current Medtronic Consultant/

More information

Endo-Thermal Heat Induced Thrombosis (E-HIT)

Endo-Thermal Heat Induced Thrombosis (E-HIT) Endo-Thermal Heat Induced Thrombosis (E-HIT) Michael Ombrellino MD FACS The Cardiovascular Care Group Clinical Associate Professor of Surgery Rutgers School of Medicine Objectives: What is E-HIT? How do

More information

Understanding venous disease and treatment options for your patients. Christopher Wulff, MD

Understanding venous disease and treatment options for your patients. Christopher Wulff, MD Understanding venous disease and treatment options for your patients Christopher Wulff, MD Understanding Chronic venous insufficiency (CVI) Important Statistics About CVI Affects all age groups 1 Is ten

More information

6/1/2017. Mechanico-Chemical Ablation MOCA? Disclaimer

6/1/2017. Mechanico-Chemical Ablation MOCA? Disclaimer Cox Health Venous Symposium June 2-3, 207 Mechanico-Chemical Ablation Non-thermal, Non-tumescent Venous Ablation Therapy ROBERT W. VORHIES, M.D., F.A.C.S. VASCULAR AND ENDOVASCULAR SURGERY ENDOVENOUS THERAPY

More information

GSV treatment with Radio Frequency EVRF device and CR45i catheter CLINICAL STUDY

GSV treatment with Radio Frequency EVRF device and CR45i catheter CLINICAL STUDY GSV treatment with Radio Frequency EVRF device and CR45i catheter CLINICAL STUDY _ BY Dr. Thomas Niesen St Louis Surgical Consultant 226 South Wood Mills Road, Suite 49 West Chesterfield, Mo 63017 Tel:

More information

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS UnitedHealthcare Commercial Medical Policy SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS Policy Number: 2018T0447V Effective Date: March 1, 2018 Table of Contents Page INSTRUCTIONS

More information

The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency. A Prospective, Multi-centre Study

The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency. A Prospective, Multi-centre Study The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency A Prospective, Multi-centre Study Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor

More information

Srovnání 2 typů radiálních laserových vláken (1-ringových a 2-ringových) v nitrožilní léčbě křečových žil pomocí laseru o vlnové délce 1470 nm

Srovnání 2 typů radiálních laserových vláken (1-ringových a 2-ringových) v nitrožilní léčbě křečových žil pomocí laseru o vlnové délce 1470 nm Srovnání 2 typů radiálních laserových vláken (1-ringových a 2-ringových) v nitrožilní léčbě křečových žil pomocí laseru o vlnové délce 1470 nm Robert Vlachovský, Robert Staffa, Ernest Biroš II. chirurgická

More information

A treatment option for varicose veins. enefit" Targeted Endovenous Therapy. Formerly known as the VNUS Closure procedure E 3 COVIDIEN

A treatment option for varicose veins. enefit Targeted Endovenous Therapy. Formerly known as the VNUS Closure procedure E 3 COVIDIEN A treatment option for varicose veins. enefit" Targeted Endovenous Therapy Formerly known as the VNUS Closure procedure E 3 COVIDIEN THE VENOUS SYSTEM ANATOMY The venous system is made up of a network

More information

Long-term follow up for different varicose vein therapies: is surgery still. the best?

Long-term follow up for different varicose vein therapies: is surgery still. the best? Long-term follow up for different varicose vein therapies: is surgery still the best? Mr Roshan BOOTUN [BSc, MBBS, MRCS] Clinical Research Fellow in Vascular Surgery Professor Alun H. DAVIES [BA, BM BCh,

More information

Which place for liquid sclerotherapy? Eberhard Rabe Department of Dermatology University of Bonn Germany

Which place for liquid sclerotherapy? Eberhard Rabe Department of Dermatology University of Bonn Germany Which place for liquid sclerotherapy? Eberhard Rabe Department of Dermatology University of Bonn Germany Liquid Foam or GSV, foam / liquid sclerosant n diameter[mm] Follow up effectivity Hamel Desnos 2003

More information

Medicare C/D Medical Coverage Policy

Medicare C/D Medical Coverage Policy Varicose Vein Treatment Medicare C/D Medical Coverage Policy Origination Date: June 1, 1993 Review Date: February 15, 2017 Next Review: February, 2019 DESCRIPTION OF PROCEDURE OR SERVICE Varicose veins

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of cyanoacrylate glue occlusion for varicose veins Varicose veins in the legs are

More information

RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY

RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY Paul Kramer, MD, FACC, FSCAI Liberty Cardiovascular Specialists Liberty Regional Heart and Vascular Center DISCLOSURES NONE Venous

More information

Chronic Venous Insufficiency Compression and Beyond

Chronic Venous Insufficiency Compression and Beyond Disclosure of Conflict of Interest Chronic Venous Insufficiency Compression and Beyond Shawn Amyot, MD, CCFP Fellow of the Canadian Society of Phlebology Ottawa Vein Centre I do not have relevant financial

More information

Venous Disease and Leg Ulcers. Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL

Venous Disease and Leg Ulcers. Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL Venous Disease and Leg Ulcers Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL Disclosures Stocks Endoshape Sapheon Medical Advisory Board BTG, Boston Scientific Venous Leg Ulcer Most common

More information

Complete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction. Erin H. Murphy, MD Rane Center

Complete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction. Erin H. Murphy, MD Rane Center Complete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction Erin H. Murphy, MD Rane Center Disclosure Speaker name: Erin H. Murphy... I have the following potential conflicts

More information

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS UnitedHealthcare Commercial Medical Policy SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS Policy Number: 2017T0447T Effective Date: July 1, 2017 Table of Contents Page INSTRUCTIONS

More information

Research Article Effects of Two Current Great Saphenous Vein Thermal Ablation Methods on Visual Analog Scale and Quality of Life

Research Article Effects of Two Current Great Saphenous Vein Thermal Ablation Methods on Visual Analog Scale and Quality of Life Hindawi BioMed Research International Volume 2017, Article ID 8532149, 6 pages https://doi.org/10.1155/2017/8532149 Research Article Effects of Two Current Great Saphenous Vein Thermal Ablation Methods

More information

Sadie Ahanchi, MD Sentara Vascular Specialists April 27,2018. Debate 1: Why Is Tumescent-Based Therapy The Gold Standard?

Sadie Ahanchi, MD Sentara Vascular Specialists April 27,2018. Debate 1: Why Is Tumescent-Based Therapy The Gold Standard? Sadie Ahanchi, MD Sentara Vascular Specialists April 27,2018 Debate 1: Why Is Tumescent-Based Therapy The Gold Standard? Tumescent based venous therapy: Fight! Introduction Tumescent anesthesia Administration

More information

Current Management of Varicose Veins

Current Management of Varicose Veins Current Management of Varicose Veins Michael J. Heidenreich, MD St. Joseph Mercy Hospital Ann Arbor, MI March 23, 2013 Nothing to disclose History Prevalence Anatomy Risk factors Clinical manifestations

More information

TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY

TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY TL LUK Consultant Vascular Surgeon Sarawak General Hospital HKL Vascular Conference 19/06/2013 PREVALENCE OF LOWER LIMB VENOUS DISEASE Affects half of

More information

LINC, Christine Teichert, MD University Medicine of Rostock, Dept. of diagnostic and interventional radiology, Germany

LINC, Christine Teichert, MD University Medicine of Rostock, Dept. of diagnostic and interventional radiology, Germany Comparison of the efficacy, safety, the primary and secondary technical success of the endovenous nonthermal, tumescensless mechanochemical ablation of varicose veins with the subjective outcome using

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of endovenous mechanochemical ablation for varicose veins Varicose veins in the legs

More information

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS UnitedHealthcare Oxford Clinical Policy SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS Policy Number: OUTPATIENT 013.32 T2 Effective Date: February 1, 2018 Table of Contents

More information

Laser and Radiofrequency Ablation Study (LARA study): A Randomised Study Comparing Radiofrequency Ablation and Endovenous Laser Ablation (810 nm)

Laser and Radiofrequency Ablation Study (LARA study): A Randomised Study Comparing Radiofrequency Ablation and Endovenous Laser Ablation (810 nm) Eur J Vasc Endovasc Surg (2010) 40, 246e253 Laser and Radiofrequency Ablation Study (LARA study): A Randomised Study Comparing Radiofrequency Ablation and Endovenous Laser Ablation (810 nm) S.D. Goode,

More information

VIRTUS: Trial Design and Primary Endpoint Results

VIRTUS: Trial Design and Primary Endpoint Results VIRTUS: Trial Design and Primary Endpoint Results Mahmood K. Razavi, MD St. Joseph Cardiac and Vascular Center Orange, CA, USA IMPORTANT INFORMATION: These materials are intended to describe common clinical

More information

Do Venous Procedures Have an Impact on Quality of Life? Mark H. Meissner, MD Professor of Surgery University of Washington Seattle, WA USA

Do Venous Procedures Have an Impact on Quality of Life? Mark H. Meissner, MD Professor of Surgery University of Washington Seattle, WA USA Do Venous Procedures Have an Impact on Quality of Life? Mark H. Meissner, MD Professor of Surgery University of Washington Seattle, WA USA Venous Outcome Measures Technical Clinical Functional Acute DVT

More information

SAVE LIMBS SAVE LIVES! Endovenous Ablation for Chronic Wounds

SAVE LIMBS SAVE LIVES! Endovenous Ablation for Chronic Wounds SAVE LIMBS SAVE LIVES! Endovenous Ablation for Chronic Wounds Frank J. Tursi, DPM, FACFS Clinical Associate Professor, University of Pennsylvania/Presbyterian Foot and Ankle Consultant, Philadelphia Flyers,

More information

Treatment of Varicose Veins/Venous Insufficiency

Treatment of Varicose Veins/Venous Insufficiency Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

SAFETY AND FEASIBILITY OF MECHANO-CHEMICAL ABLATION OF VARICOSE VEINS: INITIAL RESULTS

SAFETY AND FEASIBILITY OF MECHANO-CHEMICAL ABLATION OF VARICOSE VEINS: INITIAL RESULTS SAFETY AND FEASIBILITY OF MECHANO-CHEMICAL ABLATION OF VARICOSE VEINS: INITIAL RESULTS Michel M.P.J. Reijnen, M.D., Ph.D. Jean-Paul P.M. de Vries, M.D., Ph.D. Rijnstate Hospital, Arnhem, The Netherlands

More information

Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden

Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden Disclosures No disclosures Five sources for comparison SVS/AVF US guidelines

More information

Chronic Venous Insufficiency

Chronic Venous Insufficiency Chronic Venous Insufficiency None Disclosures Lesley Enfinger, MSN,NP-C Chronic Venous Insufficiency Over 24 Million Americans affected by Chronic Venous Insufficiency (CVI) 10 x More Americans suffer

More information

Table XI. Reference Abstracts corresponding to references can be found using the listing RCTs by alphabetical order or RCTs by topic.

Table XI. Reference Abstracts corresponding to references can be found using the listing RCTs by alphabetical order or RCTs by topic. Table XI. Operative procedure EVLA with different wavelengths HL+ EVLA EVLA without HL EVLA GSV ablation AK GSV ablation AK+BK Reference Abstracts corresponding to references can be found using the listing

More information

Le varici recidive Recurrent varices: how to manage them?

Le varici recidive Recurrent varices: how to manage them? Le varici recidive Recurrent varices: how to manage them? Marianne De Maeseneer MD PhD, Vascular Surgeon Department of Dermatology, Rotterdam, Netherlands & Faculty of Medicine and Health Sciences University

More information

Additional Information S-55

Additional Information S-55 Additional Information S-55 Network providers are encouraged, but not required to participate in the on-line American Venous Forum Registry (AVR) - The First National Registry for the Treatment of Varicose

More information

Vein Disease Treatment

Vein Disease Treatment MP9241 Covered Service: Yes when meets criteria below Prior Authorization Required: Yes as indicated in 2.0, 3.0, 4.0 and 5.0 Additional Information: None Prevea360 Health Plan Medical Policy: Vein disease

More information

Deep Venous Pathology. Eberhard Rabe Department of Dermatology University of Bonn Germany

Deep Venous Pathology. Eberhard Rabe Department of Dermatology University of Bonn Germany Deep Venous Pathology Eberhard Rabe Department of Dermatology University of Bonn Germany Disclosures None for this presentation Consultant: Sigvaris, EUROCOM Speakers bureau: Bayer Vital, Aspen, Boehringer,

More information

New Technologies in Superficial Vein Treatment

New Technologies in Superficial Vein Treatment New Technologies in Superficial Vein Treatment Ariel D. Soffer, MD, FACC Associate Clinical Professor Florida International University Medical School Ariel Soffer, MD, FACC Bio Fellow of the American College

More information

OHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009

OHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009 OHTAC Recommendation Endovascular Laser Treatment for Varicose Veins Presented to the Ontario Health Technology Advisory Committee in November 2009 April 2010 Issue Background The Ontario Health Technology

More information

Treatment of Varicose Veins/Venous Insufficiency

Treatment of Varicose Veins/Venous Insufficiency MEDICAL POLICY 7.01.519 Treatment of Varicose Veins/Venous Insufficiency BCBSA Ref. Policy: 7.01.124 Effective Date: March 1, 2017 Last Revised: Jan. 23, 2018 Replaces: 7.01.55, 7.01.76, 7.01.515, and

More information

Endovenous laser obliteration for the treatment of primary varicose veins Vuylsteke M, Van den Bussche D, Audenaert E A, Lissens P

Endovenous laser obliteration for the treatment of primary varicose veins Vuylsteke M, Van den Bussche D, Audenaert E A, Lissens P Endovenous laser obliteration for the treatment of primary varicose veins Vuylsteke M, Van den Bussche D, Audenaert E A, Lissens P Record Status This is a critical abstract of an economic evaluation that

More information

Recurrent Varicose Veins We All See Them

Recurrent Varicose Veins We All See Them We All See Them November 4, 2017 Austin, TX Arlington Heights, IL No conflicts Terminology REVAS REcurrent Varices After Surgery PREVAIT PREsence of Varices After Interventional Treatment Recurrent varices

More information

Techniques and Specific Treatment Modalities for the Active Non-Healing Wound. Luke Maj, MD, MHA

Techniques and Specific Treatment Modalities for the Active Non-Healing Wound. Luke Maj, MD, MHA Techniques and Specific Treatment Modalities for the Active Non-Healing Wound Luke Maj, MD, MHA Assistant Professor of Radiology University of Miami, Miller School of Medicine Director of The Vein Center

More information

RE: Request for coverage and reimbursement for mechano-chemical venous ablation Clarivein

RE: Request for coverage and reimbursement for mechano-chemical venous ablation Clarivein October 7, 2016 Craig Haug, MD JK MAC Medical Director NHIC, Corp. Hewlett Packard Enterprise 75 William Terry Dr., Hingham, MA 02043 Dear Dr. Haug: RE: Request for coverage and reimbursement for mechano-chemical

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Varicose Veins Page 1 of 37 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Varicose Veins Professional Institutional Original Effective Date: January 1, 2004 Original

More information

Management of Side Branches and Perforating Veins

Management of Side Branches and Perforating Veins Management of Side Branches and Perforating Veins T. Noppeney Center for Vascular Diseases: Outpatient Dept. Obere Turnstrasse, Dept. for Vascular Surgery Martha-Maria Hospital (Academic Teaching Hospital

More information

o Self-Contained & Disposable: Fully self-contained, single-use device with no need for capital equipment purchase

o Self-Contained & Disposable: Fully self-contained, single-use device with no need for capital equipment purchase The ClariVein OC Proprietary dual action device^ ClariVein OC is a specialty catheter for the infusion of physician-specified agents in the peripheral vasculature including for endovascular occlusion of

More information

The occlusion rate and patterns of saphenous vein after radiofrequency ablation

The occlusion rate and patterns of saphenous vein after radiofrequency ablation J Korean Surg Soc 2013;84:107-113 http://dx.doi.org/10.4174/jkss.2013.84.2.107 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 The occlusion rate and patterns

More information

GENTLE ABLATION WITH RFITT TECHNOLOGY. For varicose vein treatment

GENTLE ABLATION WITH RFITT TECHNOLOGY. For varicose vein treatment GENTLE ABLATION WITH RFITT TECHNOLOGY For varicose vein treatment CELON RFITT METHOD For healthy and beautiful legs CELON has developed a leading bipolar radiofrequency ablation (RFA) system that can be

More information

Disclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach.

Disclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach. Management of Venous Disease: an evidence based approach Disclosures Ed Boyle, MD Andrew Jones, MD Dr. Ed Boyle and Dr. Andrew Jones disclose Grants/research support: Medtronic, BTG International, Clearflow,

More information

New Guideline in venous ulcer treatment: dressing, medication, intervention

New Guideline in venous ulcer treatment: dressing, medication, intervention New Guideline in venous ulcer treatment: dressing, medication, intervention Kittipan Rerkasem, FRCS(T), PhD Department of Surgery Faculty of Medicine Chiang Mai University Topic Overview venous ulcer treatment

More information

CHRONIC VENOUS INSUFFICIENCY of the lower extremities

CHRONIC VENOUS INSUFFICIENCY of the lower extremities Radiofrequency Ablation: Evolution of a Treatment Joann Lohr, MD, FACS, RVT, and Aaron Kulwicki, MD Superficial venous insufficiency of the lower extremities is a common affliction. There are several modalities

More information

Thrombosis of the Saphenous Vein Stump after Varicose Vein Surgery

Thrombosis of the Saphenous Vein Stump after Varicose Vein Surgery 2016 Annals of Vascular Diseases doi:10.300/avd.oa.16-000 Original Article Thrombosis of the Saphenous Vein Stump Varicose Vein Surgery Hiroto Rikimaru, MD, PhD We evaluated thrombus extension in the proximal

More information

Varicose vein treatment radiofrequency ablation (ClosureFast)

Varicose vein treatment radiofrequency ablation (ClosureFast) Varicose vein treatment radiofrequency ablation (ClosureFast) Vascular Surgery Patient Information Leaflet Introduction This leaflet is to help answer any questions you may have about radiofrequency ablation

More information

WHAT ABOUT FOAM SCLEROTHERAPY IN REVAS? Dr O CRETON Ste FOY LES LYON

WHAT ABOUT FOAM SCLEROTHERAPY IN REVAS? Dr O CRETON Ste FOY LES LYON WHAT ABOUT FOAM SCLEROTHERAPY IN REVAS? Dr O CRETON Ste FOY LES LYON Disclosure of Interest I have the following potential conflicts of interest to report: Consulting: Medtronic WHAT ABOUT REVAS? Source

More information

Randomized clinical comparison of short term outcomes following endogenous laser ablation and stripping in patients with saphenous vein insufficiency

Randomized clinical comparison of short term outcomes following endogenous laser ablation and stripping in patients with saphenous vein insufficiency Original Research 12 endogenous laser ablation and stripping in patients with saphenous vein Ozgur Bulut*, Umit Halici, Serdar Menekse Department of Cardiovascular Surgery Education and Research Hospital,

More information

Influence of Warfarin on the Success of Endovenous Laser Ablation (EVLA) of the Great Saphenous Vein (GSV)

Influence of Warfarin on the Success of Endovenous Laser Ablation (EVLA) of the Great Saphenous Vein (GSV) Eur J Vasc Endovasc Surg (2009) 38, 506e510 Influence of Warfarin on the Success of Endovenous Laser Ablation (EVLA) of the Great Saphenous Vein (GSV) N.S. Theivacumar, M.J. Gough* Leeds Vascular Institute,

More information

Thermal Ablation 101: Basics of RF and Laser

Thermal Ablation 101: Basics of RF and Laser 1:48-2:00 Now 11 min flying Thermal ablation indications, contraindications, results, complications (30 min) Thermal Ablation 101: Basics of RF and Laser Nick Morrison, MD, FACPh, FACS, RPhS President,

More information

The evidence for venous interventions is evolving- many patients do actually benefit. Nils Kucher University Hospital Bern Switzerland

The evidence for venous interventions is evolving- many patients do actually benefit. Nils Kucher University Hospital Bern Switzerland The evidence for venous interventions is evolving- many patients do actually benefit Nils Kucher University Hospital Bern Switzerland Disclosure Speaker name: Nils Kucher X X I have the following potential

More information

Radiofrequency ablation of varicose veins using bipolar device: A step by step approach

Radiofrequency ablation of varicose veins using bipolar device: A step by step approach Radiofrequency ablation of varicose veins using bipolar device: A step by step approach Poster No.: C-1152 Congress: ECR 2013 Type: Educational Exhibit Authors: V. Kasi Arunachalam, M. K. yadav, K. P.

More information

Varicose Vein Cyanoacrylate Glue treatment

Varicose Vein Cyanoacrylate Glue treatment The South West s premier independent healthcare and cosmetic clinic Varicose Vein Cyanoacrylate Glue treatment Varicose veins are a sign of underlying venous insufficiency and affect 20 30% of adults.

More information

Venous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC

Venous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC Venous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label

More information

chapter 4 Randomized clinical trial of steam ablation (LAST trial) for great saphenous varicose veins

chapter 4 Randomized clinical trial of steam ablation (LAST trial) for great saphenous varicose veins Randomized clinical trial of EVSA versus EVLA 1 http://hdl.handle.net/1765/111020 chapter 4 Randomized clinical trial of endovenous Randomized clinical laser trial ablation of endovenous versus laser ablation

More information

VENASEAL CLOSURE SYSTEM

VENASEAL CLOSURE SYSTEM Sponsored by Medtronic Fall 2015 VENASEAL CLOSURE SYSTEM Is Cyanoacrylate Safe for Peripheral Venous Applications? By Nick Morrison, MD, FACPh, FACS, RPhS Clinical EvidenceBehind the VenaSeal Closure System

More information

The Vascular Disease Almost No One Teaches But Should!!! Chronic Venous Insufficiency

The Vascular Disease Almost No One Teaches But Should!!! Chronic Venous Insufficiency The Vascular Disease Almost No One Teaches But Should!!! Chronic Venous Insufficiency Thomas E. Eidson, DO Certified Venous Disease Specialist Board Certified Family Medicine Disclosure of Conflict of

More information

Priorities Forum Statement

Priorities Forum Statement Priorities Forum Statement Number 9 Subject Varicose Vein Surgery Date of decision September 2014 Date refreshed March 2017 Date of review September 2018 Relevant OPCS codes: L841-46, L848-49, L851-53,

More information

Comparison of Endovenous Laser and Radiofrequency Ablation in Treating Varicose Veins in the Same Patient

Comparison of Endovenous Laser and Radiofrequency Ablation in Treating Varicose Veins in the Same Patient Original Manuscript Comparison of Endovenous Laser and Radiofrequency Ablation in Treating Varicose Veins in the Same Patient Vascular and Endovascular Surgery 2016, Vol. 50(1) 47-51 ª The Author(s) 2016

More information

Catheter-based treatments for varicose veins: evidence and practice.

Catheter-based treatments for varicose veins: evidence and practice. imeet May 2018, Nice France Catheter-based treatments for varicose veins: evidence and practice. Marc Vuylsteke MD PhD Vascular Surgeon Sint-Andriesziekenhuis Tielt Belgium Venous Disease C0: 38.5% C1:

More information